NVO - Novo Nordisk's Wegovy Success Uplifts Denmark's Economy And Reputation But With Caution | Benzinga
Novo Nordisk A/S's (NYSE: NVO) remarkable success with its weight-loss treatment, Wegovy, is not only a cause for celebration but also a source of caution for Denmark.
The company's rise to the top of Europe's most valuable listed companies, surpassing even luxury giant LVMH Moet Hennessy Louis Vuitton SA (OTC: LVMUY) (OTC: LVMHF), has brought substantial economic benefits to the country.
In August, the Danish government revised its annual economic growth forecast, crediting Novo's achievements, which have translated ...